1. Home
  2. STXS vs ETN Comparison

STXS vs ETN Comparison

Compare STXS & ETN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • ETN
  • Stock Information
  • Founded
  • STXS 1990
  • ETN 1916
  • Country
  • STXS United States
  • ETN Ireland
  • Employees
  • STXS N/A
  • ETN N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ETN Industrial Machinery/Components
  • Sector
  • STXS Health Care
  • ETN Technology
  • Exchange
  • STXS Nasdaq
  • ETN Nasdaq
  • Market Cap
  • STXS 151.3M
  • ETN N/A
  • IPO Year
  • STXS 2004
  • ETN N/A
  • Fundamental
  • Price
  • STXS $2.18
  • ETN $307.04
  • Analyst Decision
  • STXS
  • ETN Buy
  • Analyst Count
  • STXS 0
  • ETN 17
  • Target Price
  • STXS N/A
  • ETN $355.31
  • AVG Volume (30 Days)
  • STXS 285.8K
  • ETN 3.0M
  • Earning Date
  • STXS 05-12-2025
  • ETN 05-02-2025
  • Dividend Yield
  • STXS N/A
  • ETN 1.35%
  • EPS Growth
  • STXS N/A
  • ETN 17.05
  • EPS
  • STXS N/A
  • ETN 9.91
  • Revenue
  • STXS $26,918,000.00
  • ETN $25,312,000,000.00
  • Revenue This Year
  • STXS $25.90
  • ETN $8.61
  • Revenue Next Year
  • STXS $60.57
  • ETN $7.70
  • P/E Ratio
  • STXS N/A
  • ETN $30.97
  • Revenue Growth
  • STXS 0.55
  • ETN 7.00
  • 52 Week Low
  • STXS $1.54
  • ETN $231.85
  • 52 Week High
  • STXS $2.72
  • ETN $379.99
  • Technical
  • Relative Strength Index (RSI)
  • STXS 66.61
  • ETN 63.87
  • Support Level
  • STXS $1.93
  • ETN $286.60
  • Resistance Level
  • STXS $2.07
  • ETN $306.10
  • Average True Range (ATR)
  • STXS 0.09
  • ETN 8.96
  • MACD
  • STXS 0.03
  • ETN 3.15
  • Stochastic Oscillator
  • STXS 94.05
  • ETN 94.61

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: